Flatiron Health

Flatiron Health provides an oncology-specific electronic health record (EHR) platform designed exclusively for cancer care providers, including community oncology practices, academic cancer centers, and hospital-based oncology departments. Acquired by Roche in 2018 for $1.9 billion, Flatiron operates as an independent affiliate focused on technology-enabled cancer care and oncology research infrastructure. The platform's core differentiator lies in its dual purpose architecture: it functions as